Hologic Inc (HOLX)

$74.87 +0.01 (0.01%)
Market Cap 16.69B
Revenue (ttm) 4.10B
Net Income (ttm) 565.70M
EPS (ttm) N/A
PE Ratio 17.53
Forward PE 16.62
Profit Margin 13.80%
Debt to Equity Ratio 0.50
Volume 1,511,600
Avg Vol 2,906,528
Day's Range N/A - N/A
Shares Out 222.91M
Stochastic %K 63%
Beta 0.69
Analysts Hold
Price Target $76.85

Company Profile

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, an...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 508 263 2900
Address:
250 Campus Drive, Marlborough, United States
SuperGreenToday
SuperGreenToday Jan. 13 at 9:35 PM
$HOLX Share Price: $74.87 Contract Selected: Jun 18, 2026 $75 Calls Buy Zone: $1.02 – $1.26 Target Zone: $1.82 – $2.22 Potential Upside: 68% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 1:18 PM
$HOLX's Breast Health segment gains spotlight with Blackstone & TPG's take-private transaction! 💰 The deal includes a CVR of up to $3/share, tied to Breast Health's global revenue metrics for FY2026 & FY2027. Shares up 11% in 3 months, outpacing the industry's 3.7% growth. 📈 See how analysts are projecting Hologic’s fiscal 2026 and 2027 earnings 👉 https://www.zacks.com/stock/news/2812346/hologics-breast-health-unit-stays-in-focus-in-2026-what-lies-ahead?cid=sm-stocktwits-2-2812346-body-27445&ADID=SYND_STOCKTWITS_TWEET_2_2812346_BODY_27445
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 12:18 PM
$HOLX back in the spotlight — and this deal just raised the stakes 💰 The Breast Health unit is drawing fresh attention after a proposed Blackstone-TPG transaction featuring a $76 cash offer plus a CVR tied to 2026–27 revenue goals. That’s a clear signal where the value focus is right now. Full breakdown of what this deal structure could mean 👉 https://www.zacks.com/stock/news/2812346/hologics-breast-health-unit-stays-in-focus-in-2026-what-lies-ahead?cid=sm-stocktwits-2-2812346-teaser-27442&ADID=SYND_STOCKTWITS_TWEET_2_2812346_TEASER_27442
0 · Reply
ZacksResearch
ZacksResearch Jan. 5 at 12:21 PM
Is $HOLX ready for a breakout or a cautionary hold? 📈👀 Hologic surged 15.9% in six months, outpacing the S&P 500 and its industry. Yet, macro headwinds like tariffs remain a concern. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2811660/hologic-trading-near-52-week-high-how-should-you-play-the-stock?cid=sm-stocktwits-2-2811660-body-27236&ADID=SYND_STOCKTWITS_TWEET_2_2811660_BODY_27236
0 · Reply
ZacksResearch
ZacksResearch Jan. 5 at 11:21 AM
🚨 $HOLX flirting with its 52-week high — momentum is real, but risks aren’t gone. Diagnostics growth and AI adoption are pushing the stock higher, fueling optimism around the business trajectory 📈 At the same time, tariffs and ongoing challenges in China remain clear headwinds investors can’t ignore ⚠️ Full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2811660/hologic-trading-near-52-week-high-how-should-you-play-the-stock?cid=sm-stocktwits-2-2811660-teaser-27233&ADID=SYND_STOCKTWITS_TWEET_2_2811660_TEASER_27233
0 · Reply
SaraSheridan1075
SaraSheridan1075 Jan. 2 at 4:03 PM
$ALB $CX $DOW $HOLX $Z Clear analysis
0 · Reply
Few_erish
Few_erish Dec. 26 at 8:40 PM
$HOLX Flat range day then a small late push, looks like quiet absorption under the lid
0 · Reply
ZacksResearch
ZacksResearch Dec. 26 at 1:18 PM
$HOLX's gynecological devices segment is on fire! 🔥 Revenues hit $679.8M in fiscal 2025, a 6% jump from 2024, driven by a combination of strong sales of Myosure and NovaSure devices, and contributions from the Fluent fluid management system. Key acquisitions like Acessa Health and Gynesonics are boosting growth prospects. Discover the full potential for HOLX in this expanding market 👉 https://www.zacks.com/stock/news/2809021/hologics-gyn-surgical-segment-looks-poised-for-long-term-growth?cid=sm-stocktwits-2-2809021-body-26388&ADID=SYND_STOCKTWITS_TWEET_2_2809021_BODY_26388
0 · Reply
ZacksResearch
ZacksResearch Dec. 26 at 12:03 PM
$HOLX GYN Surgical is heating up — and the momentum looks real 🔥 Rising global demand for gynecological devices is driving growth, fueled by innovation, M&A activity, and strong overseas adoption across the GYN Surgical unit. See what’s powering this momentum and why it matters 👉 https://www.zacks.com/stock/news/2809021/hologics-gyn-surgical-segment-looks-poised-for-long-term-growth?cid=sm-stocktwits-2-2809021-teaser-26359&ADID=SYND_STOCKTWITS_TWEET_2_2809021_TEASER_26359
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 1:57 PM
$HOLX vs. $LH — Which MedTech stock should you bet on? 🤔 Labcorp’s strategic partnerships and innovation in high-growth areas give it an edge, with analysts targeting a 19.3% upside. Meanwhile, Hologic's strength in diagnostics and breast health, along with M&A contributions, continue to support its performance. Find out which stock has the better outlook here 👉 https://www.zacks.com/stock/news/2807138/holx-vs-lh-which-medtech-stock-is-the-stronger-investment-now?cid=sm-stocktwits-2-2807138-body-25762&ADID=SYND_STOCKTWITS_TWEET_2_2807138_BODY_25762
0 · Reply
Latest News on HOLX
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening

Jan 13, 2026, 9:00 AM EST - 22 hours ago

Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening

Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams

Dec 16, 2025, 8:08 AM EST - 4 weeks ago

Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams

New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

Dec 2, 2025, 8:10 AM EST - 6 weeks ago

New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA

Nov 25, 2025, 8:08 AM EST - 7 weeks ago

New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA

Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking

Nov 12, 2025, 8:11 AM EST - 2 months ago

Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025

Nov 3, 2025, 4:01 PM EST - 2 months ago

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025

Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

Oct 22, 2025, 4:56 PM EDT - 2 months ago

Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

Oct 21, 2025, 9:18 AM EDT - 3 months ago

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

BX TPG

Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal

Oct 21, 2025, 8:48 AM EDT - 3 months ago

Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal

BX TPG

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Oct 21, 2025, 8:41 AM EDT - 3 months ago

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

Oct 20, 2025, 7:55 AM EDT - 3 months ago

Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

BX TPG

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

Oct 2, 2025, 4:04 PM EDT - 3 months ago

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

Oct 2, 2025, 8:05 AM EDT - 3 months ago

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

New Survey Results Underscore the Need to #BustTheMyth About Mammograms

Sep 30, 2025, 8:15 AM EDT - 3 months ago

New Survey Results Underscore the Need to #BustTheMyth About Mammograms

Volition Signs Co-Marketing and Services Agreement with Hologic

Sep 29, 2025, 9:30 AM EDT - 3 months ago

Volition Signs Co-Marketing and Services Agreement with Hologic

VNRX

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

Sep 29, 2025, 9:30 AM EDT - 3 months ago

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

Sep 26, 2025, 8:00 AM EDT - 3 months ago

New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

Blackstone and TPG revive interest in buying Hologic, source says

Sep 17, 2025, 4:41 PM EDT - 4 months ago

Blackstone and TPG revive interest in buying Hologic, source says

BX TPG

Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 2:05 PM EDT - 4 months ago

Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Sep 3, 2025, 4:02 PM EDT - 4 months ago

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript

Jul 30, 2025, 7:12 PM EDT - 5 months ago

Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript

Hologic raises annual profit forecast on diagnostic and surgical demand

Jul 30, 2025, 6:06 PM EDT - 5 months ago

Hologic raises annual profit forecast on diagnostic and surgical demand

Hologic Announces Financial Results for Third Quarter of Fiscal 2025

Jul 30, 2025, 4:01 PM EDT - 5 months ago

Hologic Announces Financial Results for Third Quarter of Fiscal 2025

Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy

Jul 22, 2025, 5:06 PM EDT - 6 months ago

Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

Jul 2, 2025, 4:05 PM EDT - 6 months ago

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

Jun 2, 2025, 11:03 AM EDT - 8 months ago

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

May 27, 2025, 3:48 PM EDT - 8 months ago

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

May 27, 2025, 1:05 PM EDT - 8 months ago

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

BX TPG

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

May 22, 2025, 5:05 PM EDT - 8 months ago

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

Hologic to Webcast Presentations at Upcoming Investor Conferences

May 13, 2025, 4:10 PM EDT - 8 months ago

Hologic to Webcast Presentations at Upcoming Investor Conferences

Hologic: Soft Performance, But Cheap Enough

May 6, 2025, 5:39 PM EDT - 9 months ago

Hologic: Soft Performance, But Cheap Enough

Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript

May 1, 2025, 8:24 PM EDT - 9 months ago

Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript

Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty

May 1, 2025, 6:58 PM EDT - 9 months ago

Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

May 1, 2025, 4:01 PM EDT - 9 months ago

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Apr 25, 2025, 4:25 AM EDT - 9 months ago

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Apr 24, 2025, 8:10 AM EDT - 9 months ago

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report

Apr 22, 2025, 8:08 AM EDT - 9 months ago

Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report

Wayde McMillan Elected to Hologic Board of Directors

Apr 4, 2025, 4:15 PM EDT - 10 months ago

Wayde McMillan Elected to Hologic Board of Directors

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Apr 3, 2025, 4:30 PM EDT - 10 months ago

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Feb 25, 2025, 8:15 AM EST - 11 months ago

Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Feb 20, 2025, 3:00 AM EST - 11 months ago

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Feb 18, 2025, 8:08 AM EST - 11 months ago

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Hologic, Inc. (HOLX) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 10:06 PM EST - 1 year ago

Hologic, Inc. (HOLX) Q1 2025 Earnings Call Transcript

Hologic cuts annual revenue forecast on weak demand for breast health products

Feb 5, 2025, 5:56 PM EST - 1 year ago

Hologic cuts annual revenue forecast on weak demand for breast health products

Hologic Announces Financial Results for First Quarter of Fiscal 2025

Feb 5, 2025, 4:01 PM EST - 1 year ago

Hologic Announces Financial Results for First Quarter of Fiscal 2025

New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide

Jan 21, 2025, 8:00 AM EST - 1 year ago

New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide

SuperGreenToday
SuperGreenToday Jan. 13 at 9:35 PM
$HOLX Share Price: $74.87 Contract Selected: Jun 18, 2026 $75 Calls Buy Zone: $1.02 – $1.26 Target Zone: $1.82 – $2.22 Potential Upside: 68% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 1:18 PM
$HOLX's Breast Health segment gains spotlight with Blackstone & TPG's take-private transaction! 💰 The deal includes a CVR of up to $3/share, tied to Breast Health's global revenue metrics for FY2026 & FY2027. Shares up 11% in 3 months, outpacing the industry's 3.7% growth. 📈 See how analysts are projecting Hologic’s fiscal 2026 and 2027 earnings 👉 https://www.zacks.com/stock/news/2812346/hologics-breast-health-unit-stays-in-focus-in-2026-what-lies-ahead?cid=sm-stocktwits-2-2812346-body-27445&ADID=SYND_STOCKTWITS_TWEET_2_2812346_BODY_27445
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 12:18 PM
$HOLX back in the spotlight — and this deal just raised the stakes 💰 The Breast Health unit is drawing fresh attention after a proposed Blackstone-TPG transaction featuring a $76 cash offer plus a CVR tied to 2026–27 revenue goals. That’s a clear signal where the value focus is right now. Full breakdown of what this deal structure could mean 👉 https://www.zacks.com/stock/news/2812346/hologics-breast-health-unit-stays-in-focus-in-2026-what-lies-ahead?cid=sm-stocktwits-2-2812346-teaser-27442&ADID=SYND_STOCKTWITS_TWEET_2_2812346_TEASER_27442
0 · Reply
ZacksResearch
ZacksResearch Jan. 5 at 12:21 PM
Is $HOLX ready for a breakout or a cautionary hold? 📈👀 Hologic surged 15.9% in six months, outpacing the S&P 500 and its industry. Yet, macro headwinds like tariffs remain a concern. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2811660/hologic-trading-near-52-week-high-how-should-you-play-the-stock?cid=sm-stocktwits-2-2811660-body-27236&ADID=SYND_STOCKTWITS_TWEET_2_2811660_BODY_27236
0 · Reply
ZacksResearch
ZacksResearch Jan. 5 at 11:21 AM
🚨 $HOLX flirting with its 52-week high — momentum is real, but risks aren’t gone. Diagnostics growth and AI adoption are pushing the stock higher, fueling optimism around the business trajectory 📈 At the same time, tariffs and ongoing challenges in China remain clear headwinds investors can’t ignore ⚠️ Full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2811660/hologic-trading-near-52-week-high-how-should-you-play-the-stock?cid=sm-stocktwits-2-2811660-teaser-27233&ADID=SYND_STOCKTWITS_TWEET_2_2811660_TEASER_27233
0 · Reply
SaraSheridan1075
SaraSheridan1075 Jan. 2 at 4:03 PM
$ALB $CX $DOW $HOLX $Z Clear analysis
0 · Reply
Few_erish
Few_erish Dec. 26 at 8:40 PM
$HOLX Flat range day then a small late push, looks like quiet absorption under the lid
0 · Reply
ZacksResearch
ZacksResearch Dec. 26 at 1:18 PM
$HOLX's gynecological devices segment is on fire! 🔥 Revenues hit $679.8M in fiscal 2025, a 6% jump from 2024, driven by a combination of strong sales of Myosure and NovaSure devices, and contributions from the Fluent fluid management system. Key acquisitions like Acessa Health and Gynesonics are boosting growth prospects. Discover the full potential for HOLX in this expanding market 👉 https://www.zacks.com/stock/news/2809021/hologics-gyn-surgical-segment-looks-poised-for-long-term-growth?cid=sm-stocktwits-2-2809021-body-26388&ADID=SYND_STOCKTWITS_TWEET_2_2809021_BODY_26388
0 · Reply
ZacksResearch
ZacksResearch Dec. 26 at 12:03 PM
$HOLX GYN Surgical is heating up — and the momentum looks real 🔥 Rising global demand for gynecological devices is driving growth, fueled by innovation, M&A activity, and strong overseas adoption across the GYN Surgical unit. See what’s powering this momentum and why it matters 👉 https://www.zacks.com/stock/news/2809021/hologics-gyn-surgical-segment-looks-poised-for-long-term-growth?cid=sm-stocktwits-2-2809021-teaser-26359&ADID=SYND_STOCKTWITS_TWEET_2_2809021_TEASER_26359
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 1:57 PM
$HOLX vs. $LH — Which MedTech stock should you bet on? 🤔 Labcorp’s strategic partnerships and innovation in high-growth areas give it an edge, with analysts targeting a 19.3% upside. Meanwhile, Hologic's strength in diagnostics and breast health, along with M&A contributions, continue to support its performance. Find out which stock has the better outlook here 👉 https://www.zacks.com/stock/news/2807138/holx-vs-lh-which-medtech-stock-is-the-stronger-investment-now?cid=sm-stocktwits-2-2807138-body-25762&ADID=SYND_STOCKTWITS_TWEET_2_2807138_BODY_25762
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 12:02 PM
$HOLX vs. $LH — only one can be the stronger MedTech play right now 👀 This head-to-head breaks down which of these two MedTech names stacks up better as an investment right now, cutting straight to the strengths that matter most for investors. See which stock comes out on top 👉 https://www.zacks.com/stock/news/2807138/holx-vs-lh-which-medtech-stock-is-the-stronger-investment-now?cid=sm-stocktwits-2-2807138-teaser-25719&ADID=SYND_STOCKTWITS_TWEET_2_2807138_TEASER_25719
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 5:34 PM
$HOLX dips — but this AI data turns heads 🧠🩺 Hologic unveiled new study results showing its Genius AI mammography flagged 32% of previously missed breast cancer cases, even as shares moved lower on the news. Dig into what the data really means for HOLX 👉 https://www.zacks.com/stock/news/2805755/holxs-genius-ai-mammography-flags-missed-breast-cancer-cases?cid=sm-stocktwits-2-2805755-teaser-25302&ADID=SYND_STOCKTWITS_TWEET_2_2805755_TEASER_25302
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 4:34 PM
Is $HOLX's AI revolutionizing mammography? 🤔 Hologic's Genius AI Detection flagged 32% of false-negative cases as "suspicious," showcasing its potential to enhance breast cancer detection. Despite this, HOLX shares edged down 0.2% following the news announcement. Discover how AI is shaping HOLX's future here 👉 https://www.zacks.com/stock/news/2805755/holxs-genius-ai-mammography-flags-missed-breast-cancer-cases?cid=sm-stocktwits-2-2805755-body-25231&ADID=SYND_STOCKTWITS_TWEET_2_2805755_BODY_25231
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 2:25 PM
$HOLX surges 10% in 3 months — is it time to keep an eye on it? 🚀 Hologic's AI-powered mammography solutions are gaining traction, with new data highlighting their potential to improve cancer detection rates. Plus, HOLX is trading at a forward P/S of 3.86X, undercutting the industry average of 4.36X. 📊 See how analysts are projecting Hologic’s fiscal 2026 and 2027 earnings 👉 https://www.zacks.com/stock/news/2805426/hologics-genius-ai-detection-shows-value-by-spotting-missed-cancers?cid=sm-stocktwits-2-2805426-body-25172&ADID=SYND_STOCKTWITS_TWEET_2_2805426_BODY_25172
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 12:29 PM
🚨 $HOLX quietly leveling up breast cancer detection — this is a big deal Genius AI Detection is flagging breast cancers that were previously missed, showing real promise in boosting mammography accuracy and making radiologists more efficient. That’s a powerful combo for better outcomes and workflow gains. 🧠📈 See how this AI tech could change breast cancer screening 👉 https://www.zacks.com/stock/news/2805426/hologics-genius-ai-detection-shows-value-by-spotting-missed-cancers?cid=sm-stocktwits-2-2805426-teaser-25112&ADID=SYND_STOCKTWITS_TWEET_2_2805426_TEASER_25112
0 · Reply
ZacksResearch
ZacksResearch Dec. 12 at 12:38 PM
$HOLX diagnostics poised for growth — what's fueling the expansion? 🚀 📈 Diagnostics revenues up 1.5% in fiscal Q4 2025 in constant currency on core U.S. molecular sales 🧪 Panther Fusion's efficiency & flexibility driving future growth ✅ New FDA & CE approvals strengthen market position Discover the key catalysts for Hologic here 👉 https://www.zacks.com/stock/news/2803467/what-is-driving-hologics-strength-in-the-us-diagnostics-market?cid=sm-stocktwits-2-2803467-body-24550&ADID=SYND_STOCKTWITS_TWEET_2_2803467_BODY_24550
0 · Reply
ZacksResearch
ZacksResearch Dec. 12 at 11:38 AM
$HOLX’s growth engine is kicking into a higher gear. U.S. molecular testing is driving a clear acceleration in Diagnostics, and the new Panther Fusion and Genius platform approvals are giving HOLX a wider runway to work with. See how this sets up the full investment case 👉 https://www.zacks.com/stock/news/2803467/what-is-driving-hologics-strength-in-the-us-diagnostics-market?cid=sm-stocktwits-2-2803467-teaser-24540&ADID=SYND_STOCKTWITS_TWEET_2_2803467_TEASER_24540
0 · Reply
ZacksResearch
ZacksResearch Dec. 8 at 3:11 PM
Is $HOLX running out of steam after a 16% six-month run? The move’s been fueled by solid divisional strength, fresh clinical data, and even a go-private deal shaping the near-term setup — but that also makes the “Hold” call heading into 2026 a real question mark. Full outlook breakdown here 👉 https://www.zacks.com/stock/news/2800879/holx-stock-up-16-in-6-months-is-it-still-a-hold-heading-into-2026?cid=sm-stocktwits-2-2800879-teaser-23772&ADID=SYND_STOCKTWITS_TWEET_2_2800879_TEASER_23772
0 · Reply
ZacksResearch
ZacksResearch Dec. 8 at 2:11 PM
$HOLX: Is it time to hold or cash out? 🤔 Hologic's 6-month rally is backed by clinical strength and innovation, but with shares near the $76 go-private offer, short-term gains might be limited. Trading above the 50-day SMA and with a forward P/S lower than its own median hint at potential value. 📈 Find out if holding HOLX makes sense 👉 https://www.zacks.com/stock/news/2800879/holx-stock-up-16-in-6-months-is-it-still-a-hold-heading-into-2026?cid=sm-stocktwits-2-2800879-body-23771&ADID=SYND_STOCKTWITS_TWEET_2_2800879_BODY_23771
0 · Reply
ZacksResearch
ZacksResearch Dec. 4 at 6:31 PM
Is $HOLX quietly building a bigger moat in oncology testing? Its BCI test is gaining traction, and new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions — momentum that’s hard to ignore. Full breakdown here 👉 https://www.zacks.com/stock/news/2799647/hologics-bci-test-shows-growing-impact-in-endocrine-therapy-decisions?cid=sm-stocktwits-2-2799647-teaser-23545&ADID=SYND_STOCKTWITS_TWEET_2_2799647_TEASER_23545
0 · Reply
ZacksResearch
ZacksResearch Dec. 4 at 5:31 PM
$HOLX gaining momentum — is it undervalued? 📈 In just six months, Hologic shares have surged 18.9%, outpacing the industry’s 14% growth. With a forward five-year P/S of 3.87X, it’s trading below the industry average of 4.39X, suggesting potential value. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2799647/hologics-bci-test-shows-growing-impact-in-endocrine-therapy-decisions?cid=sm-stocktwits-2-2799647-body-23521&ADID=SYND_STOCKTWITS_TWEET_2_2799647_BODY_23521
0 · Reply
firsthole
firsthole Nov. 29 at 7:01 PM
$HOLX $FEMY Holli swooping in? Serious question?!!
0 · Reply